- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02732496
Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome
August 2, 2018 updated by: Mary Zelime Elibol, Massachusetts General Hospital
Computerized Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder and Comorbid Tourette Syndrome
The investigators will conduct a randomized placebo-controlled trial of a computerized intervention targeting working memory in 30 children with comorbid Attention-Deficit/Hyperactivity Disorder (ADHD) and Tourette Syndrome (TS).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Because impairments in executive functions (EFs), such as working memory, are associated with functional impairments in youth with neurodevelopmental and neuropsychiatric disorders, strategies that target EFs are critical.
Neuroplasticity-based cognitive training has been found to improve cognition in youth with ADHD and in adults with schizophrenia.
In this trial, the investigators seek to extend the relevance of computerized cognitive training to youth with comorbid ADHD and Tourette Syndrome.
Given the literature, the investigators hypothesize that computerized working memory training will produce gains in untrained cognitive tasks and behavioral ratings of executive functions in youth with ADHD+TS.
The investigators will assess aspects of attention and executive functions in 30 affected youth and randomize them 1:1 to either neuroplasticity-based cognitive training or enjoyable age-appropriate computer games not intended to improve cognition.
Cognition will be assessed again after 30 training sessions over 6 weeks and then again at a one-month follow-up.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 13 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The investigators will limit inclusion to youth between the ages of 7-13 who carry current diagnoses of ADHD+TS and who have a treating physician at a Partners affiliated hospital or clinic.
- The investigators will include youth who have undergone neuropsychological testing in the prior 3 years.
Exclusion Criteria:
- The investigators will exclude patients with intellectual disability in order to more directly extend the prior literature to the ADHD+TS population.
- The investigators will exclude patients with severe tics as evidenced by a score of > 30 on the clinician administered Yale Global Tic Severity Scale (YGTSS).
- The investigators will exclude patients with moderate to severe Obsessive Compulsive Disorder (OCD) symptoms, as evidenced by a score of >30 on the clinician administered Children's Yale-Brown Obsessive Compulsive Scale (CYBOCS).
- The investigators will exclude patients treated with neuroleptics, given that these medications can be cognitively dulling and sedating and potentially lead to secondary working memory impairments.
- The investigators will exclude families who do not have a computer with an internet connection in their homes, and in which neither a parent nor the child has an email address to receive study related communications.
- The investigators will exclude families who anticipate or are likely to have a change in therapeutic treatments (i.e., psychotherapy or psychopharmacology) during the time frame of the trial.
NOTE: Patients treated with ADHD medications will not be excluded, but medications will be recorded for covariate analysis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Cognitive Training
Targeted Cognitive Training (TCT)
|
The instructors have selected a set of computer exercises designed to specifically target working memory, which is a cognitive construct relevant to ADHD and Tourette Syndrome.
The tasks were designed to benefit subjects through principles of learning-dependent plasticity.
|
|
PLACEBO_COMPARATOR: Youth Appropriate Online Games
Engaging games not designed to improve cognition
|
Engaging games not designed to improve cognition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spatial Working Memory (SWM) subtest from the Cambridge Neuropsychological Test Automated Battery (CANTAB)
Time Frame: 3 months
|
The SWM subtest assesses working memory.
|
3 months
|
|
Spatial Span (SSP) subtest from the Cambridge Neuropsychological Test Automated Battery (CANTAB)
Time Frame: 3 months
|
The SSP subtest assesses working memory.
|
3 months
|
|
The Working Memory Index from the Behavior Rating Inventory of Executive Function (BRIEF)
Time Frame: 3 months
|
Parent and teacher ratings on the Working Memory Index of the BRIEF assess working memory.
|
3 months
|
|
The Behavioral Regulation Index from the Behavior Rating Inventory of Executive Function (BRIEF)
Time Frame: 3 months
|
Parent and teacher ratings on the Behavioral Regulation Index of the BRIEF assess working memory.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: M. Zelime Elibol, MD, Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2016
Primary Completion (ACTUAL)
November 3, 2017
Study Completion (ACTUAL)
November 3, 2017
Study Registration Dates
First Submitted
March 3, 2016
First Submitted That Met QC Criteria
April 4, 2016
First Posted (ESTIMATE)
April 8, 2016
Study Record Updates
Last Update Posted (ACTUAL)
August 3, 2018
Last Update Submitted That Met QC Criteria
August 2, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Disease
- Genetic Diseases, Inborn
- Basal Ganglia Diseases
- Movement Disorders
- Neurodegenerative Diseases
- Dyskinesias
- Heredodegenerative Disorders, Nervous System
- Attention Deficit and Disruptive Behavior Disorders
- Neurodevelopmental Disorders
- Tic Disorders
- Syndrome
- Attention Deficit Disorder with Hyperactivity
- Hyperkinesis
- Tourette Syndrome
Other Study ID Numbers
- 2015P002512
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.